Jazz Pharmaceuticals Appoints New Chief Medical Officer and CLO
Ticker: JAZZ · Form: 8-K · Filed: Dec 16, 2024 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, management-change
TL;DR
Jazz Pharma beefs up exec team with new CMO & CLO.
AI Summary
On December 11, 2024, Jazz Pharmaceuticals plc announced changes to its executive team. The company appointed two new officers: Dr. Robert I. Tepper as Chief Medical Officer and Ms. Jennifer L. W. D. Smith as Chief Legal Officer and Corporate Secretary. These appointments are effective immediately.
Why It Matters
The appointment of key executive roles like Chief Medical Officer and Chief Legal Officer can signal strategic shifts in research, development, or legal strategy for the company.
Risk Assessment
Risk Level: low — The filing reports routine executive appointments and compensatory arrangements, which are standard corporate disclosures.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- Dr. Robert I. Tepper (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. W. D. Smith (person) — Appointed Chief Legal Officer and Corporate Secretary
- December 11, 2024 (date) — Effective date of appointments
FAQ
Who were the new officers appointed by Jazz Pharmaceuticals?
Jazz Pharmaceuticals appointed Dr. Robert I. Tepper as Chief Medical Officer and Ms. Jennifer L. W. D. Smith as Chief Legal Officer and Corporate Secretary.
When were these appointments effective?
The appointments were effective immediately as of December 11, 2024.
What are the new roles filled by the appointees?
Dr. Robert I. Tepper was appointed Chief Medical Officer, and Ms. Jennifer L. W. D. Smith was appointed Chief Legal Officer and Corporate Secretary.
What is the company's full legal name and jurisdiction of incorporation?
The company's full legal name is Jazz Pharmaceuticals Public Limited Company, and it is incorporated in Ireland.
What is the filing date of this Current Report?
The Current Report was filed as of December 16, 2024, with the earliest event reported being December 11, 2024.
Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 13.3 · Accepted 2024-12-16 16:43:58
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
Filing Documents
- d907309d8k.htm (8-K) — 21KB
- 0001193125-24-279656.txt ( ) — 143KB
- jazz-20241211.xsd (EX-101.SCH) — 3KB
- jazz-20241211_lab.xml (EX-101.LAB) — 18KB
- jazz-20241211_pre.xml (EX-101.PRE) — 11KB
- d907309d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/ Neena Patil Name: Neena Patil Title: Executive Vice President and Chief Legal Officer Date: December 16, 2024